Verrica Pharmaceuticals Inc (VRCA)
8.67
-0.48
(-5.25%)
USD |
NASDAQ |
May 17, 16:00
8.99
+0.32
(+3.69%)
After-Hours: 17:30
Verrica Pharmaceuticals Total Assets (Quarterly): 66.31M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 66.31M |
| December 31, 2023 | 81.60M |
| September 30, 2023 | 97.15M |
| June 30, 2023 | 62.20M |
| March 31, 2023 | 68.64M |
| December 31, 2022 | 44.72M |
| September 30, 2022 | 49.15M |
| June 30, 2022 | 63.44M |
| March 31, 2022 | 71.62M |
| December 31, 2021 | 80.12M |
| September 30, 2021 | 88.76M |
| June 30, 2021 | 99.03M |
| March 31, 2021 | 108.10M |
| Date | Value |
|---|---|
| December 31, 2020 | 74.15M |
| September 30, 2020 | 79.94M |
| June 30, 2020 | 87.24M |
| March 31, 2020 | 94.44M |
| December 31, 2019 | 68.42M |
| September 30, 2019 | 76.07M |
| June 30, 2019 | 81.25M |
| March 31, 2019 | 85.98M |
| December 31, 2018 | 91.91M |
| September 30, 2018 | 98.80M |
| June 30, 2018 | 104.72M |
| March 31, 2018 | 29.40M |
| December 31, 2017 | 9.083M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
44.72M
Minimum
Dec 2022
108.10M
Maximum
Mar 2021
77.12M
Average
78.00M
Median
Total Assets (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 129.52M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 48.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 64.80M |
| Shareholders Equity (Quarterly) | 1.508M |
| Debt to Equity Ratio | 28.41 |
| Current Ratio | 3.169 |
| Net Debt Paydown Yield | -3.41% |